NOVARTIS INDIA LTD. - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Mr. Felix Doss has tendered his resignation from the position of Chief Financial Officer of the Company, to pursue opportunities outside of Novartis. The resignation has been accepted and he will be relieved from his responsibilities at the end of business hours on December 31, 2021. The Company is in the process of identifying a suitable successor and the same will be communicated to the stock exchange, once the position is filled up. Kindly take note of the above on record.